Zhejiang Medicine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2,977	3,167	1,966	1,460	1,438	1,769
Short-Term Investments	-	-	-	-	-	2.9
Trading Asset Securities	262.29	250.32	294.91	328.31	447.29	454.4
Cash & Short-Term Investments	3,240	3,418	2,261	1,788	1,885	2,226
Cash Growth	29.16%	51.17%	26.41%	-5.15%	-15.30%	14.17%
Accounts Receivable	1,801	1,674	1,830	1,419	1,501	1,594
Other Receivables	116.43	115.26	194.79	239.14	67.35	105.17
Receivables	1,918	1,790	2,025	1,658	1,568	1,699
Inventory	1,797	1,855	2,133	2,011	1,995	1,873
Prepaid Expenses	-	-	-	-	0.03	0.36
Other Current Assets	198.89	149.36	166.46	143.88	207.17	236.04
Total Current Assets	7,153	7,211	6,585	5,601	5,655	6,035
Property, Plant & Equipment	5,807	5,904	6,121	6,019	5,618	5,360
Long-Term Investments	359.8	137.75	156.51	166.21	144.51	126.07
Goodwill	-	-	-	18.68	27.91	36.03
Other Intangible Assets	622.52	603.44	684.4	744.3	747.68	728.81
Long-Term Deferred Tax Assets	105.54	125.43	124.94	82.12	77.41	78.8
Long-Term Deferred Charges	8.71	8.77	12.81	6.22	8.85	0.41
Other Long-Term Assets	121.56	99.68	110.66	141.15	153.27	167.76
Total Assets	14,179	14,091	13,795	12,780	12,433	12,532
Accounts Payable	974.35	814.63	744.68	744.03	702.48	897.83
Accrued Expenses	124.55	532.95	544.93	534.16	263.98	287.32
Short-Term Debt	300.26	243.21	278.28	208.22	82.25	225.33
Current Portion of Long-Term Debt	152.42	273.24	306.3	370.37	550.64	-
Current Portion of Leases	-	0.34	0.56	0.3	0.28	-
Current Income Taxes Payable	84.53	78.56	170.55	11.88	21.75	153.51
Current Unearned Revenue	51.59	32	29.31	43.95	61.88	53.81
Other Current Liabilities	423.68	464.85	494.84	565.52	782.11	1,407
Total Current Liabilities	2,111	2,440	2,569	2,478	2,465	3,025
Long-Term Debt	504.37	357.25	171.15	230.22	200.19	250.34
Long-Term Leases	0.3	0.36	0.14	0.32	0.62	1.16
Long-Term Unearned Revenue	124.73	130.5	104.6	84.16	54.11	53.08
Long-Term Deferred Tax Liabilities	-	-	-	-	2.47	21.12
Other Long-Term Liabilities	72.61	73.7	82.2	-	-	-
Total Liabilities	2,813	3,002	2,928	2,793	2,723	3,350
Common Stock	961.64	961.64	961.64	964.98	965.13	965.13
Additional Paid-In Capital	1,889	1,871	1,988	2,005	1,941	1,692
Retained Earnings	8,508	8,221	7,700	6,682	6,417	6,195
Treasury Stock	-125.49	-125.49	-	-27.63	-57.69	-59.98
Comprehensive Income & Other	7.3	15.27	-1.36	5.77	-5.27	-13.99
Total Common Equity	11,241	10,943	10,648	9,631	9,260	8,779
Minority Interest	124.49	145.69	219.8	355.68	449.98	402.93
Shareholders' Equity	11,365	11,089	10,868	9,986	9,710	9,182
Total Liabilities & Equity	14,179	14,091	13,795	12,780	12,433	12,532
Total Debt	957.35	874.41	756.43	809.44	833.97	476.82
Net Cash (Debt)	2,282	2,543	1,504	978.89	1,051	1,749
Net Cash Growth	33.35%	69.06%	53.67%	-6.90%	-39.89%	75.16%
Net Cash Per Share	2.39	2.66	1.57	1.03	1.09	1.82
Filing Date Shares Outstanding	956.71	947.91	961.64	902.84	958.3	958.3
Total Common Shares Outstanding	956.71	947.91	961.64	902.84	958.3	958.3
Working Capital	5,042	4,771	4,015	3,123	3,190	3,010
Book Value Per Share	11.75	11.54	11.07	10.67	9.66	9.16
Tangible Book Value	10,618	10,340	9,964	8,868	8,484	8,014
Tangible Book Value Per Share	11.10	10.91	10.36	9.82	8.85	8.36
Buildings	-	3,303	3,032	2,919	2,812	2,509
Machinery	-	7,953	7,418	6,897	6,158	5,366
Construction In Progress	-	627.3	982.5	931.69	825.71	1,119

Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.